middle.news
Cogstate Doubles Contract Sales and Boosts Dividend on Record FY26 Performance
8:12am on Tuesday 18th of August, 2026 AEST
•
Healthcare
Read Story
Cogstate Doubles Contract Sales and Boosts Dividend on Record FY26 Performance
8:12am on Tuesday 18th of August, 2026 AEST
Key Points
FY26 clinical trial sales contracts surge 116% to $89 million
Total revenue climbs 15% to $60.9 million with 58% gross margin
EBITDA margin steady at 30%, EBIT margin improves to 25%
Contracted future revenue rises 32% to $118.5 million
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Cogstate (ASX:CGS)
OPEN ARTICLE